The global Antibiotics for Dogs and Cats market was valued at US$ 258.7 million in 2023 and is anticipated to reach US$ 418.2 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.

Antibiotics for Dogs and Cats Market

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 718%.

This report aims to provide a comprehensive presentation of the global market for Antibiotics for Dogs and Cats, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibiotics for Dogs and Cats.

Report Scope

The Antibiotics for Dogs and Cats market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibiotics for Dogs and Cats market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antibiotics for Dogs and Cats manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antibiotics for Dogs and Cats Market Report

Report Metric	Details
Report Name	Antibiotics for Dogs and Cats Market
Accounted market size in 2023	US$ 258.7 million
Forecasted market size in 2030	US$ 418.2 million
CAGR	5.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Tetracyclines Penicillins Sulfonamides Macrolides Aminoglycosides Cephalosporins Others
Segment by Application	Cats Dogs
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Huvepharma, Merck & Co, Ceva Animal Health, Zoetis, Crystal Pharma, Afrivet, Elanco, Merck Animal Health, Merial, Bayer Animal Health, Virbac, Ceva, Boehringer Ingelheim, Vetoquinol, Phibro Animal Health, NCPC, LKPC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antibiotics for Dogs and Cats manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antibiotics for Dogs and Cats in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Antibiotics for Dogs and Cats Market growing?

Ans: The Antibiotics for Dogs and Cats Market witnessing a CAGR of 5.9% during the forecast period 2024-2030.

What is the Antibiotics for Dogs and Cats Market size in 2030?

Ans: The Antibiotics for Dogs and Cats Market size in 2030 will be US$ 418.2 million.

What is the Antibiotics for Dogs and Cats Market share by region?

Ans: In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Antibiotics for Dogs and Cats Market report?

Ans: The main players in the Antibiotics for Dogs and Cats Market are Huvepharma, Merck & Co, Ceva Animal Health, Zoetis, Crystal Pharma, Afrivet, Elanco, Merck Animal Health, Merial, Bayer Animal Health, Virbac, Ceva, Boehringer Ingelheim, Vetoquinol, Phibro Animal Health, NCPC, LKPC

What are the Application segmentation covered in the Antibiotics for Dogs and Cats Market report?

Ans: The Applications covered in the Antibiotics for Dogs and Cats Market report are Cats, Dogs

What are the Type segmentation covered in the Antibiotics for Dogs and Cats Market report?

Ans: The Types covered in the Antibiotics for Dogs and Cats Market report are Tetracyclines, Penicillins, Sulfonamides, Macrolides, Aminoglycosides, Cephalosporins, Others

1 Antibiotics for Dogs and Cats Market Overview

1.1 Product Overview and Scope of Antibiotics for Dogs and Cats

1.2 Antibiotics for Dogs and Cats Segment by Type

1.2.1 Global Antibiotics for Dogs and Cats Market Value Comparison by Type (2024-2030)

1.2.2 Tetracyclines

1.2.3 Penicillins

1.2.4 Sulfonamides

1.2.5 Macrolides

1.2.6 Aminoglycosides

1.2.7 Cephalosporins

1.2.8 Others

1.3 Antibiotics for Dogs and Cats Segment by Application

1.3.1 Global Antibiotics for Dogs and Cats Market Value by Application: (2024-2030)

1.3.2 Cats

1.3.3 Dogs

1.4 Global Antibiotics for Dogs and Cats Market Size Estimates and Forecasts

1.4.1 Global Antibiotics for Dogs and Cats Revenue 2019-2030

1.4.2 Global Antibiotics for Dogs and Cats Sales 2019-2030

1.4.3 Global Antibiotics for Dogs and Cats Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Antibiotics for Dogs and Cats Market Competition by Manufacturers

2.1 Global Antibiotics for Dogs and Cats Sales Market Share by Manufacturers (2019-2024)

2.2 Global Antibiotics for Dogs and Cats Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Antibiotics for Dogs and Cats Average Price by Manufacturers (2019-2024)

2.4 Global Antibiotics for Dogs and Cats Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Antibiotics for Dogs and Cats, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Antibiotics for Dogs and Cats, Product Type & Application

2.7 Antibiotics for Dogs and Cats Market Competitive Situation and Trends

2.7.1 Antibiotics for Dogs and Cats Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Antibiotics for Dogs and Cats Players Market Share by Revenue

2.7.3 Global Antibiotics for Dogs and Cats Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Antibiotics for Dogs and Cats Retrospective Market Scenario by Region

3.1 Global Antibiotics for Dogs and Cats Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Antibiotics for Dogs and Cats Global Antibiotics for Dogs and Cats Sales by Region: 2019-2030

3.2.1 Global Antibiotics for Dogs and Cats Sales by Region: 2019-2024

3.2.2 Global Antibiotics for Dogs and Cats Sales by Region: 2025-2030

3.3 Global Antibiotics for Dogs and Cats Global Antibiotics for Dogs and Cats Revenue by Region: 2019-2030

3.3.1 Global Antibiotics for Dogs and Cats Revenue by Region: 2019-2024

3.3.2 Global Antibiotics for Dogs and Cats Revenue by Region: 2025-2030

3.4 North America Antibiotics for Dogs and Cats Market Facts & Figures by Country

3.4.1 North America Antibiotics for Dogs and Cats Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Antibiotics for Dogs and Cats Sales by Country (2019-2030)

3.4.3 North America Antibiotics for Dogs and Cats Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Antibiotics for Dogs and Cats Market Facts & Figures by Country

3.5.1 Europe Antibiotics for Dogs and Cats Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Antibiotics for Dogs and Cats Sales by Country (2019-2030)

3.5.3 Europe Antibiotics for Dogs and Cats Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Antibiotics for Dogs and Cats Market Facts & Figures by Country

3.6.1 Asia Pacific Antibiotics for Dogs and Cats Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Antibiotics for Dogs and Cats Sales by Country (2019-2030)

3.6.3 Asia Pacific Antibiotics for Dogs and Cats Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Antibiotics for Dogs and Cats Market Facts & Figures by Country

3.7.1 Latin America Antibiotics for Dogs and Cats Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Antibiotics for Dogs and Cats Sales by Country (2019-2030)

3.7.3 Latin America Antibiotics for Dogs and Cats Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Antibiotics for Dogs and Cats Market Facts & Figures by Country

3.8.1 Middle East and Africa Antibiotics for Dogs and Cats Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Antibiotics for Dogs and Cats Sales by Country (2019-2030)

3.8.3 Middle East and Africa Antibiotics for Dogs and Cats Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Antibiotics for Dogs and Cats Sales by Type (2019-2030)

4.1.1 Global Antibiotics for Dogs and Cats Sales by Type (2019-2024)

4.1.2 Global Antibiotics for Dogs and Cats Sales by Type (2025-2030)

4.1.3 Global Antibiotics for Dogs and Cats Sales Market Share by Type (2019-2030)

4.2 Global Antibiotics for Dogs and Cats Revenue by Type (2019-2030)

4.2.1 Global Antibiotics for Dogs and Cats Revenue by Type (2019-2024)

4.2.2 Global Antibiotics for Dogs and Cats Revenue by Type (2025-2030)

4.2.3 Global Antibiotics for Dogs and Cats Revenue Market Share by Type (2019-2030)

4.3 Global Antibiotics for Dogs and Cats Price by Type (2019-2030)

5 Segment by Application

5.1 Global Antibiotics for Dogs and Cats Sales by Application (2019-2030)

5.1.1 Global Antibiotics for Dogs and Cats Sales by Application (2019-2024)

5.1.2 Global Antibiotics for Dogs and Cats Sales by Application (2025-2030)

5.1.3 Global Antibiotics for Dogs and Cats Sales Market Share by Application (2019-2030)

5.2 Global Antibiotics for Dogs and Cats Revenue by Application (2019-2030)

5.2.1 Global Antibiotics for Dogs and Cats Revenue by Application (2019-2024)

5.2.2 Global Antibiotics for Dogs and Cats Revenue by Application (2025-2030)

5.2.3 Global Antibiotics for Dogs and Cats Revenue Market Share by Application (2019-2030)

5.3 Global Antibiotics for Dogs and Cats Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Huvepharma

6.1.1 Huvepharma Corporation Information

6.1.2 Huvepharma Description and Business Overview

6.1.3 Huvepharma Antibiotics for Dogs and Cats Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Huvepharma Antibiotics for Dogs and Cats Product Portfolio

6.1.5 Huvepharma Recent Developments/Updates

6.2 Merck & Co

6.2.1 Merck & Co Corporation Information

6.2.2 Merck & Co Description and Business Overview

6.2.3 Merck & Co Antibiotics for Dogs and Cats Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Merck & Co Antibiotics for Dogs and Cats Product Portfolio

6.2.5 Merck & Co Recent Developments/Updates

6.3 Ceva Animal Health

6.3.1 Ceva Animal Health Corporation Information

6.3.2 Ceva Animal Health Description and Business Overview

6.3.3 Ceva Animal Health Antibiotics for Dogs and Cats Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Ceva Animal Health Antibiotics for Dogs and Cats Product Portfolio

6.3.5 Ceva Animal Health Recent Developments/Updates

6.4 Zoetis

6.4.1 Zoetis Corporation Information

6.4.2 Zoetis Description and Business Overview

6.4.3 Zoetis Antibiotics for Dogs and Cats Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Zoetis Antibiotics for Dogs and Cats Product Portfolio

6.4.5 Zoetis Recent Developments/Updates

6.5 Crystal Pharma

6.5.1 Crystal Pharma Corporation Information

6.5.2 Crystal Pharma Description and Business Overview

6.5.3 Crystal Pharma Antibiotics for Dogs and Cats Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Crystal Pharma Antibiotics for Dogs and Cats Product Portfolio

6.5.5 Crystal Pharma Recent Developments/Updates

6.6 Afrivet

6.6.1 Afrivet Corporation Information

6.6.2 Afrivet Description and Business Overview

6.6.3 Afrivet Antibiotics for Dogs and Cats Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Afrivet Antibiotics for Dogs and Cats Product Portfolio

6.6.5 Afrivet Recent Developments/Updates

6.7 Elanco

6.6.1 Elanco Corporation Information

6.6.2 Elanco Description and Business Overview

6.6.3 Elanco Antibiotics for Dogs and Cats Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Elanco Antibiotics for Dogs and Cats Product Portfolio

6.7.5 Elanco Recent Developments/Updates

6.8 Merck Animal Health

6.8.1 Merck Animal Health Corporation Information

6.8.2 Merck Animal Health Description and Business Overview

6.8.3 Merck Animal Health Antibiotics for Dogs and Cats Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Merck Animal Health Antibiotics for Dogs and Cats Product Portfolio

6.8.5 Merck Animal Health Recent Developments/Updates

6.9 Merial

6.9.1 Merial Corporation Information

6.9.2 Merial Description and Business Overview

6.9.3 Merial Antibiotics for Dogs and Cats Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Merial Antibiotics for Dogs and Cats Product Portfolio

6.9.5 Merial Recent Developments/Updates

6.10 Bayer Animal Health

6.10.1 Bayer Animal Health Corporation Information

6.10.2 Bayer Animal Health Description and Business Overview

6.10.3 Bayer Animal Health Antibiotics for Dogs and Cats Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Bayer Animal Health Antibiotics for Dogs and Cats Product Portfolio

6.10.5 Bayer Animal Health Recent Developments/Updates

6.11 Virbac

6.11.1 Virbac Corporation Information

6.11.2 Virbac Antibiotics for Dogs and Cats Description and Business Overview

6.11.3 Virbac Antibiotics for Dogs and Cats Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Virbac Antibiotics for Dogs and Cats Product Portfolio

6.11.5 Virbac Recent Developments/Updates

6.12 Ceva

6.12.1 Ceva Corporation Information

6.12.2 Ceva Antibiotics for Dogs and Cats Description and Business Overview

6.12.3 Ceva Antibiotics for Dogs and Cats Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Ceva Antibiotics for Dogs and Cats Product Portfolio

6.12.5 Ceva Recent Developments/Updates

6.13 Boehringer Ingelheim

6.13.1 Boehringer Ingelheim Corporation Information

6.13.2 Boehringer Ingelheim Antibiotics for Dogs and Cats Description and Business Overview

6.13.3 Boehringer Ingelheim Antibiotics for Dogs and Cats Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Boehringer Ingelheim Antibiotics for Dogs and Cats Product Portfolio

6.13.5 Boehringer Ingelheim Recent Developments/Updates

6.14 Vetoquinol

6.14.1 Vetoquinol Corporation Information

6.14.2 Vetoquinol Antibiotics for Dogs and Cats Description and Business Overview

6.14.3 Vetoquinol Antibiotics for Dogs and Cats Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Vetoquinol Antibiotics for Dogs and Cats Product Portfolio

6.14.5 Vetoquinol Recent Developments/Updates

6.15 Phibro Animal Health

6.15.1 Phibro Animal Health Corporation Information

6.15.2 Phibro Animal Health Antibiotics for Dogs and Cats Description and Business Overview

6.15.3 Phibro Animal Health Antibiotics for Dogs and Cats Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Phibro Animal Health Antibiotics for Dogs and Cats Product Portfolio

6.15.5 Phibro Animal Health Recent Developments/Updates

6.16 NCPC

6.16.1 NCPC Corporation Information

6.16.2 NCPC Antibiotics for Dogs and Cats Description and Business Overview

6.16.3 NCPC Antibiotics for Dogs and Cats Sales, Revenue and Gross Margin (2019-2024)

6.16.4 NCPC Antibiotics for Dogs and Cats Product Portfolio

6.16.5 NCPC Recent Developments/Updates

6.17 LKPC

6.17.1 LKPC Corporation Information

6.17.2 LKPC Antibiotics for Dogs and Cats Description and Business Overview

6.17.3 LKPC Antibiotics for Dogs and Cats Sales, Revenue and Gross Margin (2019-2024)

6.17.4 LKPC Antibiotics for Dogs and Cats Product Portfolio

6.17.5 LKPC Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Antibiotics for Dogs and Cats Industry Chain Analysis

7.2 Antibiotics for Dogs and Cats Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Antibiotics for Dogs and Cats Production Mode & Process

7.4 Antibiotics for Dogs and Cats Sales and Marketing

7.4.1 Antibiotics for Dogs and Cats Sales Channels

7.4.2 Antibiotics for Dogs and Cats Distributors

7.5 Antibiotics for Dogs and Cats Customers

8 Antibiotics for Dogs and Cats Market Dynamics

8.1 Antibiotics for Dogs and Cats Industry Trends

8.2 Antibiotics for Dogs and Cats Market Drivers

8.3 Antibiotics for Dogs and Cats Market Challenges

8.4 Antibiotics for Dogs and Cats Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Antibiotics for Dogs and Cats Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Antibiotics for Dogs and Cats Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Antibiotics for Dogs and Cats Market Competitive Situation by Manufacturers in 2023

Table 4. Global Antibiotics for Dogs and Cats Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Antibiotics for Dogs and Cats Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Antibiotics for Dogs and Cats Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Antibiotics for Dogs and Cats Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Antibiotics for Dogs and Cats Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Antibiotics for Dogs and Cats, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Antibiotics for Dogs and Cats, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Antibiotics for Dogs and Cats, Product Type & Application

Table 12. Global Key Manufacturers of Antibiotics for Dogs and Cats, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Antibiotics for Dogs and Cats by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibiotics for Dogs and Cats as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Antibiotics for Dogs and Cats Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Antibiotics for Dogs and Cats Sales by Region (2019-2024) & (K Units)

Table 18. Global Antibiotics for Dogs and Cats Sales Market Share by Region (2019-2024)

Table 19. Global Antibiotics for Dogs and Cats Sales by Region (2025-2030) & (K Units)

Table 20. Global Antibiotics for Dogs and Cats Sales Market Share by Region (2025-2030)

Table 21. Global Antibiotics for Dogs and Cats Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Antibiotics for Dogs and Cats Revenue Market Share by Region (2019-2024)

Table 23. Global Antibiotics for Dogs and Cats Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Antibiotics for Dogs and Cats Revenue Market Share by Region (2025-2030)

Table 25. North America Antibiotics for Dogs and Cats Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Antibiotics for Dogs and Cats Sales by Country (2019-2024) & (K Units)

Table 27. North America Antibiotics for Dogs and Cats Sales by Country (2025-2030) & (K Units)

Table 28. North America Antibiotics for Dogs and Cats Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Antibiotics for Dogs and Cats Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Antibiotics for Dogs and Cats Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Antibiotics for Dogs and Cats Sales by Country (2019-2024) & (K Units)

Table 32. Europe Antibiotics for Dogs and Cats Sales by Country (2025-2030) & (K Units)

Table 33. Europe Antibiotics for Dogs and Cats Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Antibiotics for Dogs and Cats Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Antibiotics for Dogs and Cats Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Antibiotics for Dogs and Cats Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Antibiotics for Dogs and Cats Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Antibiotics for Dogs and Cats Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Antibiotics for Dogs and Cats Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Antibiotics for Dogs and Cats Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Antibiotics for Dogs and Cats Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Antibiotics for Dogs and Cats Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Antibiotics for Dogs and Cats Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Antibiotics for Dogs and Cats Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Antibiotics for Dogs and Cats Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Antibiotics for Dogs and Cats Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Antibiotics for Dogs and Cats Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Antibiotics for Dogs and Cats Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Antibiotics for Dogs and Cats Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Antibiotics for Dogs and Cats Sales (K Units) by Type (2019-2024)

Table 51. Global Antibiotics for Dogs and Cats Sales (K Units) by Type (2025-2030)

Table 52. Global Antibiotics for Dogs and Cats Sales Market Share by Type (2019-2024)

Table 53. Global Antibiotics for Dogs and Cats Sales Market Share by Type (2025-2030)

Table 54. Global Antibiotics for Dogs and Cats Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Antibiotics for Dogs and Cats Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Antibiotics for Dogs and Cats Revenue Market Share by Type (2019-2024)

Table 57. Global Antibiotics for Dogs and Cats Revenue Market Share by Type (2025-2030)

Table 58. Global Antibiotics for Dogs and Cats Price (US$/Unit) by Type (2019-2024)

Table 59. Global Antibiotics for Dogs and Cats Price (US$/Unit) by Type (2025-2030)

Table 60. Global Antibiotics for Dogs and Cats Sales (K Units) by Application (2019-2024)

Table 61. Global Antibiotics for Dogs and Cats Sales (K Units) by Application (2025-2030)

Table 62. Global Antibiotics for Dogs and Cats Sales Market Share by Application (2019-2024)

Table 63. Global Antibiotics for Dogs and Cats Sales Market Share by Application (2025-2030)

Table 64. Global Antibiotics for Dogs and Cats Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Antibiotics for Dogs and Cats Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Antibiotics for Dogs and Cats Revenue Market Share by Application (2019-2024)

Table 67. Global Antibiotics for Dogs and Cats Revenue Market Share by Application (2025-2030)

Table 68. Global Antibiotics for Dogs and Cats Price (US$/Unit) by Application (2019-2024)

Table 69. Global Antibiotics for Dogs and Cats Price (US$/Unit) by Application (2025-2030)

Table 70. Huvepharma Corporation Information

Table 71. Huvepharma Description and Business Overview

Table 72. Huvepharma Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Huvepharma Antibiotics for Dogs and Cats Product

Table 74. Huvepharma Recent Developments/Updates

Table 75. Merck & Co Corporation Information

Table 76. Merck & Co Description and Business Overview

Table 77. Merck & Co Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Merck & Co Antibiotics for Dogs and Cats Product

Table 79. Merck & Co Recent Developments/Updates

Table 80. Ceva Animal Health Corporation Information

Table 81. Ceva Animal Health Description and Business Overview

Table 82. Ceva Animal Health Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Ceva Animal Health Antibiotics for Dogs and Cats Product

Table 84. Ceva Animal Health Recent Developments/Updates

Table 85. Zoetis Corporation Information

Table 86. Zoetis Description and Business Overview

Table 87. Zoetis Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Zoetis Antibiotics for Dogs and Cats Product

Table 89. Zoetis Recent Developments/Updates

Table 90. Crystal Pharma Corporation Information

Table 91. Crystal Pharma Description and Business Overview

Table 92. Crystal Pharma Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Crystal Pharma Antibiotics for Dogs and Cats Product

Table 94. Crystal Pharma Recent Developments/Updates

Table 95. Afrivet Corporation Information

Table 96. Afrivet Description and Business Overview

Table 97. Afrivet Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Afrivet Antibiotics for Dogs and Cats Product

Table 99. Afrivet Recent Developments/Updates

Table 100. Elanco Corporation Information

Table 101. Elanco Description and Business Overview

Table 102. Elanco Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Elanco Antibiotics for Dogs and Cats Product

Table 104. Elanco Recent Developments/Updates

Table 105. Merck Animal Health Corporation Information

Table 106. Merck Animal Health Description and Business Overview

Table 107. Merck Animal Health Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Merck Animal Health Antibiotics for Dogs and Cats Product

Table 109. Merck Animal Health Recent Developments/Updates

Table 110. Merial Corporation Information

Table 111. Merial Description and Business Overview

Table 112. Merial Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Merial Antibiotics for Dogs and Cats Product

Table 114. Merial Recent Developments/Updates

Table 115. Bayer Animal Health Corporation Information

Table 116. Bayer Animal Health Description and Business Overview

Table 117. Bayer Animal Health Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Bayer Animal Health Antibiotics for Dogs and Cats Product

Table 119. Bayer Animal Health Recent Developments/Updates

Table 120. Virbac Corporation Information

Table 121. Virbac Description and Business Overview

Table 122. Virbac Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Virbac Antibiotics for Dogs and Cats Product

Table 124. Virbac Recent Developments/Updates

Table 125. Ceva Corporation Information

Table 126. Ceva Description and Business Overview

Table 127. Ceva Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Ceva Antibiotics for Dogs and Cats Product

Table 129. Ceva Recent Developments/Updates

Table 130. Boehringer Ingelheim Corporation Information

Table 131. Boehringer Ingelheim Description and Business Overview

Table 132. Boehringer Ingelheim Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Boehringer Ingelheim Antibiotics for Dogs and Cats Product

Table 134. Boehringer Ingelheim Recent Developments/Updates

Table 135. Vetoquinol Corporation Information

Table 136. Vetoquinol Description and Business Overview

Table 137. Vetoquinol Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Vetoquinol Antibiotics for Dogs and Cats Product

Table 139. Vetoquinol Recent Developments/Updates

Table 140. Phibro Animal Health Corporation Information

Table 141. Phibro Animal Health Description and Business Overview

Table 142. Phibro Animal Health Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. Phibro Animal Health Antibiotics for Dogs and Cats Product

Table 144. Phibro Animal Health Recent Developments/Updates

Table 145. NCPC Corporation Information

Table 146. NCPC Description and Business Overview

Table 147. NCPC Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 148. NCPC Antibiotics for Dogs and Cats Product

Table 149. NCPC Recent Developments/Updates

Table 150. LKPC Corporation Information

Table 151. LKPC Description and Business Overview

Table 152. LKPC Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 153. LKPC Antibiotics for Dogs and Cats Product

Table 154. LKPC Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Antibiotics for Dogs and Cats Distributors List

Table 158. Antibiotics for Dogs and Cats Customers List

Table 159. Antibiotics for Dogs and Cats Market Trends

Table 160. Antibiotics for Dogs and Cats Market Drivers

Table 161. Antibiotics for Dogs and Cats Market Challenges

Table 162. Antibiotics for Dogs and Cats Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Antibiotics for Dogs and Cats

Figure 2. Global Antibiotics for Dogs and Cats Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Antibiotics for Dogs and Cats Market Share by Type in 2023 & 2030

Figure 4. Tetracyclines Product Picture

Figure 5. Penicillins Product Picture

Figure 6. Sulfonamides Product Picture

Figure 7. Macrolides Product Picture

Figure 8. Aminoglycosides Product Picture

Figure 9. Cephalosporins Product Picture

Figure 10. Others Product Picture

Figure 11. Global Antibiotics for Dogs and Cats Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 12. Global Antibiotics for Dogs and Cats Market Share by Application in 2023 & 2030

Figure 13. Cats

Figure 14. Dogs

Figure 15. Global Antibiotics for Dogs and Cats Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Antibiotics for Dogs and Cats Market Size (2019-2030) & (US$ Million)

Figure 17. Global Antibiotics for Dogs and Cats Sales (2019-2030) & (K Units)

Figure 18. Global Antibiotics for Dogs and Cats Average Price (US$/Unit) & (2019-2030)

Figure 19. Antibiotics for Dogs and Cats Report Years Considered

Figure 20. Antibiotics for Dogs and Cats Sales Share by Manufacturers in 2023

Figure 21. Global Antibiotics for Dogs and Cats Revenue Share by Manufacturers in 2023

Figure 22. The Global 5 and 10 Largest Antibiotics for Dogs and Cats Players: Market Share by Revenue in 2023

Figure 23. Antibiotics for Dogs and Cats Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 24. Global Antibiotics for Dogs and Cats Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 25. North America Antibiotics for Dogs and Cats Sales Market Share by Country (2019-2030)

Figure 26. North America Antibiotics for Dogs and Cats Revenue Market Share by Country (2019-2030)

Figure 27. United States Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Canada Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Europe Antibiotics for Dogs and Cats Sales Market Share by Country (2019-2030)

Figure 30. Europe Antibiotics for Dogs and Cats Revenue Market Share by Country (2019-2030)

Figure 31. Germany Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. France Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. U.K. Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Italy Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Russia Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Antibiotics for Dogs and Cats Sales Market Share by Region (2019-2030)

Figure 37. Asia Pacific Antibiotics for Dogs and Cats Revenue Market Share by Region (2019-2030)

Figure 38. China Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Japan Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. South Korea Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. India Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Australia Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. China Taiwan Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Antibiotics for Dogs and Cats Sales Market Share by Country (2019-2030)

Figure 46. Latin America Antibiotics for Dogs and Cats Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Antibiotics for Dogs and Cats Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Antibiotics for Dogs and Cats Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. UAE Antibiotics for Dogs and Cats Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Antibiotics for Dogs and Cats by Type (2019-2030)

Figure 56. Global Revenue Market Share of Antibiotics for Dogs and Cats by Type (2019-2030)

Figure 57. Global Antibiotics for Dogs and Cats Price (US$/Unit) by Type (2019-2030)

Figure 58. Global Sales Market Share of Antibiotics for Dogs and Cats by Application (2019-2030)

Figure 59. Global Revenue Market Share of Antibiotics for Dogs and Cats by Application (2019-2030)

Figure 60. Global Antibiotics for Dogs and Cats Price (US$/Unit) by Application (2019-2030)

Figure 61. Antibiotics for Dogs and Cats Value Chain

Figure 62. Antibiotics for Dogs and Cats Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions